Long-Term Debt (Details)
|
3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
USD ($)
|
Jun. 30, 2012
USD ($)
|
Jun. 30, 2013
USD ($)
|
Jun. 30, 2012
USD ($)
|
Jun. 30, 2013
Novartis Note [Member]
USD ($)
|
Jun. 30, 2012
Novartis Note [Member]
USD ($)
|
Jun. 30, 2013
Novartis Note [Member]
USD ($)
|
Jun. 30, 2012
Novartis Note [Member]
USD ($)
|
Dec. 31, 2012
Novartis Note [Member]
USD ($)
|
Jun. 30, 2013
Servier Loan [Member]
USD ($)
|
Jun. 30, 2012
Servier Loan [Member]
USD ($)
|
Jul. 15, 2013
Servier Loan [Member]
|
Jun. 30, 2013
Servier Loan [Member]
USD ($)
|
Jan. 15, 2013
Servier Loan [Member]
|
Jul. 15, 2012
Servier Loan [Member]
|
Jun. 30, 2012
Servier Loan [Member]
USD ($)
|
Jan. 15, 2012
Servier Loan [Member]
|
Dec. 31, 2012
Servier Loan [Member]
USD ($)
|
Dec. 31, 2011
Servier Loan [Member]
USD ($)
|
Jun. 30, 2013
Servier Loan [Member]
EUR (€)
|
Sep. 30, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
Installment
|
Jun. 30, 2013
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Jun. 30, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Jun. 30, 2013
General Electric Capital Corporation Term Loan [Member]
USD ($)
Installment
|
Jun. 30, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Dec. 31, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Sep. 27, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Dec. 31, 2011
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Jun. 30, 2013
Other Financings [Member]
USD ($)
|
Jun. 30, 2012
Other Financings [Member]
USD ($)
|
Jun. 30, 2013
Other Financings [Member]
USD ($)
|
Jun. 30, 2012
Other Financings [Member]
USD ($)
|
|
Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||||
Maturity date | Jun. 30, 2015 | Jun. 15, 2015 | ||||||||||||||||||||||||||||||
Research and development expenses funded through loan facility, maximum (in hundredths) | 75.00% | |||||||||||||||||||||||||||||||
Maximum borrowing capacity under loan agreement | $ 50,000,000 | $ 50,000,000 | € 15,000,000 | |||||||||||||||||||||||||||||
Variable rate basis | six-month LIBOR | Euro Inter-Bank Offered Rate ("EURIBOR") | ||||||||||||||||||||||||||||||
Basis spread on variable rate (in hundredths) | 2.00% | |||||||||||||||||||||||||||||||
Interest rate at period end (in hundredths) | 2.41% | 2.41% | ||||||||||||||||||||||||||||||
Outstanding principal balance | 14,600,000 | 14,600,000 | 14,600,000 | 19,500,000 | 19,500,000 | 19,800,000 | 11,500,000 | 11,500,000 | 12,500,000 | 3,100,000 | 10,000,000 | |||||||||||||||||||||
Periodic Payment, Principal | 347,222 | |||||||||||||||||||||||||||||||
Proceeds from loan | 19,500,000 | 4,600,000 | ||||||||||||||||||||||||||||||
Increase (Decrease) in term loan obligation | 12,500,000 | |||||||||||||||||||||||||||||||
Initial interest rate during period (in hundredths) | 3.22% | |||||||||||||||||||||||||||||||
Interest rate during period (in hundredths) | 2.33% | 2.80% | 3.54% | 3.83% | ||||||||||||||||||||||||||||
Unamortized discount on debt | 8,900,000 | 8,900,000 | ||||||||||||||||||||||||||||||
Unrealized foreign exchange gain (loss) | 228,000 | 383,000 | (300,000) | 1,100,000 | 300,000 | 500,000 | ||||||||||||||||||||||||||
Unrealized foreign exchange gains related to re-measurement of loan discount | 100,000 | (400,000) | (100,000) | (200,000) | ||||||||||||||||||||||||||||
Euro to US Dollar exchange rates | 1.3007 | 1.3007 | 1.3215 | |||||||||||||||||||||||||||||
Amortization period for loan discount | 5 years | |||||||||||||||||||||||||||||||
Amortization of debt discount | 400,000 | 300,000 | 800,000 | 700,000 | ||||||||||||||||||||||||||||
Carrying value of the loan | 14,800,000 | 14,800,000 | 14,200,000 | |||||||||||||||||||||||||||||
Recognition of deferred revenue | 400,000 | 300,000 | 800,000 | 700,000 | ||||||||||||||||||||||||||||
Debt issuance costs | 200,000 | 1,300,000 | ||||||||||||||||||||||||||||||
Final payment fee | 500,000 | 500,000 | 875,000 | |||||||||||||||||||||||||||||
Fixed interest rate accrued (in hundredths) | 11.71% | 11.71% | 10.90% | |||||||||||||||||||||||||||||
Number of monthly installments | 27 | 42 | ||||||||||||||||||||||||||||||
Prepayment premium year one (in hundredths) | 3.00% | 3.00% | ||||||||||||||||||||||||||||||
Prepayment premium year two (in hundredths) | 2.00% | 2.00% | ||||||||||||||||||||||||||||||
Prepayment premium year thereafter (in hundredths) | 1.00% | 1.00% | ||||||||||||||||||||||||||||||
Aggregate number of unregistered shares of common stock called by warrants (in shares) | 263,158 | 263,158 | 39,346 | |||||||||||||||||||||||||||||
Warrants exercise price (in dollars per share) | $ 1.14 | $ 1.14 | $ 3.54 | |||||||||||||||||||||||||||||
Immediate Term for warrants exercisable (in years) | 5 years | 5 years | ||||||||||||||||||||||||||||||
Fair value of warrant liability | 26,000 | 26,000 | 200,000 | 200,000 | 100,000 | |||||||||||||||||||||||||||
Interest expense and amortization of debt issuance costs [Abstract] | ||||||||||||||||||||||||||||||||
Interest expense | $ 1,164,000 | $ 1,025,000 | $ 2,336,000 | $ 2,068,000 | $ 91,000 | $ 99,000 | $ 182,000 | $ 199,000 | $ 528,000 | $ 509,000 | $ 1,053,000 | $ 1,025,000 | $ 531,000 | $ 406,000 | $ 1,077,000 | $ 823,000 | $ 14,000 | $ 11,000 | $ 24,000 | $ 21,000 |